{"title":"Correction to “Shingles Vaccination Reduces the Risk of Parkinson's Disease”","authors":"","doi":"10.1002/cdt3.70009","DOIUrl":null,"url":null,"abstract":"<p>S. Lehrer and P. H. Rheinstein, “Shingles Vaccination Reduces the Risk of Parkinson's Disease,” <i>Chronic Diseases and Translational Medicine</i> 9 (2023): 54−57, https://doi.org/10.1002/cdt3.50.</p><p>The original article included a Conflict of Interest statement which stated: “The authors declare no conflicts of interest.” The journal and the publisher have determined that a conflict of interest on behalf of each author was not declared at publication. The journal and the publisher have had sufficient communication with the authors via email after raising questions about the Conflict of Interest in the article. The authors declared that there was no undeclared Conflict of Interest and further stated that their individual affiliations with commercial entities did not influence the research findings. Following further correspondence between the publisher and the authors, all parties have agreed to include the following Conflicts of Interest statement with the published article.</p><p><b>Conflicts of Interest</b></p><p>Steven Lehrer serves in a scientific advisory capacity with Fermata Pharma, Inc. Peter H. Rheinstein is President of Severn Health Solutions. The scientific content was developed without influence from Fermata Pharma Inc. or Severn Health Solutions.</p>","PeriodicalId":32096,"journal":{"name":"Chronic Diseases and Translational Medicine","volume":"11 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cdt3.70009","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chronic Diseases and Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cdt3.70009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
S. Lehrer and P. H. Rheinstein, “Shingles Vaccination Reduces the Risk of Parkinson's Disease,” Chronic Diseases and Translational Medicine 9 (2023): 54−57, https://doi.org/10.1002/cdt3.50.
The original article included a Conflict of Interest statement which stated: “The authors declare no conflicts of interest.” The journal and the publisher have determined that a conflict of interest on behalf of each author was not declared at publication. The journal and the publisher have had sufficient communication with the authors via email after raising questions about the Conflict of Interest in the article. The authors declared that there was no undeclared Conflict of Interest and further stated that their individual affiliations with commercial entities did not influence the research findings. Following further correspondence between the publisher and the authors, all parties have agreed to include the following Conflicts of Interest statement with the published article.
Conflicts of Interest
Steven Lehrer serves in a scientific advisory capacity with Fermata Pharma, Inc. Peter H. Rheinstein is President of Severn Health Solutions. The scientific content was developed without influence from Fermata Pharma Inc. or Severn Health Solutions.
S. Lehrer和P. H. Rheinstein,“带状疱疹疫苗接种降低帕金森病的风险”,《慢性疾病与转化医学》9(2023):54−57,https://doi.org/10.1002/cdt3.50.The原文包括利益冲突声明:“作者声明不存在利益冲突。”期刊和出版商已经确定,在发表时没有声明代表每位作者的利益冲突。在对文章中的利益冲突提出质疑后,期刊和出版商已经通过电子邮件与作者进行了充分的沟通。作者声明不存在未申报的利益冲突,并进一步表示他们与商业实体的个人关系不会影响研究结果。根据出版商和作者之间的进一步通信,所有各方都同意在发表的文章中包含以下利益冲突声明。steven Lehrer在Fermata Pharma, Inc.担任科学顾问。Peter H. Rheinstein是Severn Health Solutions的总裁。科学内容的开发不受Fermata Pharma Inc.或Severn Health Solutions的影响。
期刊介绍:
This journal aims to promote progress from basic research to clinical practice and to provide a forum for communication among basic, translational, and clinical research practitioners and physicians from all relevant disciplines. Chronic diseases such as cardiovascular diseases, cancer, diabetes, stroke, chronic respiratory diseases (such as asthma and COPD), chronic kidney diseases, and related translational research. Topics of interest for Chronic Diseases and Translational Medicine include Research and commentary on models of chronic diseases with significant implications for disease diagnosis and treatment Investigative studies of human biology with an emphasis on disease Perspectives and reviews on research topics that discuss the implications of findings from the viewpoints of basic science and clinical practic.